Pfizer : PFE

All Pfizer Articles

1533 Articles

Lee Jackson | Jul 23, 2026 at 8:13 AM EDT

Verizon Was Booted From the Dow – 5 Dividend Giants Got the Same Treatment and Eventually Soared

Getting kicked off the Dow Jones Industrial Average sounds like a death sentence for a stock, but a handful of…

Joel South | Jul 22, 2026 at 8:00 AM EDT

2 Absurdly Cheap Healthcare Stocks to Buy Before July Ends

Healthcare is quietly stealing the spotlight from mega cap tech in 2026, and two S&P 500 giants are trading at…

Lee Jackson | Jul 17, 2026 at 8:35 AM EDT

Boomers Swear by These High-Yield 5% and More Kings They Can Buy and Hold Forever

When a regular paycheck disappears in retirement, the stakes of every investment decision skyrocket. These five high-yield stocks earning 6%…

Vandita Jadeja | Jul 15, 2026 at 1:29 PM EDT

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

Johnson and Johnson has quietly become one of the best-performing mega-caps of the past year, but with a fresh pullback…

Alex Sirois | Jul 15, 2026 at 12:27 PM EDT

Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King

Johnson and Johnson just raised guidance while absorbing nine-figure litigation charges, and the stock is still near levels that have…

Trey Thoelcke | Jul 15, 2026 at 9:10 AM EDT

Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?

Both Pfizer and Gilead Sciences just flashed the same ominous technical warning while trading below analyst fair value, but the…

Vandita Jadeja | Jul 14, 2026 at 12:30 PM EDT

This Healthcare Giant Still Checks Every Box for Long-Term Investors

Johnson and Johnson just raised its full-year outlook toward a historic $100 billion revenue target, yet the stock still trades…

Alex Sirois | Jul 14, 2026 at 11:51 AM EDT

Pfizer Vs. Amgen: Bet That Pfizer’s Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

Pfizer and Amgen both grew revenue last quarter at nearly the same pace, but the engines driving that growth point…

Alex Sirois | Jul 13, 2026 at 4:47 PM EDT

Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?

Abbott is down nearly 23% this year while Pfizer dangles a 7% yield, and both just beat Q1 estimates. One…

Joel South | Jul 13, 2026 at 8:30 AM EDT

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is the easiest healthcare name to evaluate on the board heading into…

Trey Thoelcke | Jul 10, 2026 at 8:40 AM EDT

McDonald’s or Pfizer: One Offers Real Growth, One Just Pays You to Wait

Both McDonald's and Pfizer are blue-chip laggards trading at a discount, both cut reliable dividend checks, and both promise retirees…

Danielle Liverance | Jul 9, 2026 at 12:25 PM EDT

‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend

Jim Cramer stared down a stock yielding 7% and sitting near its 52-week low, and still would not tell viewers…

David Beren | Jul 9, 2026 at 12:18 PM EDT

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is the default healthcare allocation for millions of investors, and for good…

Danielle Liverance | Jul 8, 2026 at 4:07 PM EDT

3 High-Yield Dividends That Pay You Soon (But You Must Act Quickly)

Income investors watching the calendar have a narrow window this week. Three of the market’s most widely held high-yield names…

Joel South | Jul 8, 2026 at 10:26 AM EDT

3 Absurdly Cheap Dividend Stocks to Buy With $1,000 in July

The S&P 500 keeps climbing, up nearly 9% year to date, and yet a handful of large-cap dividend payers are…

1 2 3 4 … 103

Pfizer : PFE

All Pfizer Articles

Verizon Was Booted From the Dow – 5 Dividend Giants Got the Same Treatment and Eventually Soared

2 Absurdly Cheap Healthcare Stocks to Buy Before July Ends

Boomers Swear by These High-Yield 5% and More Kings They Can Buy and Hold Forever

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King

Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?

This Healthcare Giant Still Checks Every Box for Long-Term Investors

Pfizer Vs. Amgen: Bet That Pfizer’s Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

McDonald’s or Pfizer: One Offers Real Growth, One Just Pays You to Wait

‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

3 High-Yield Dividends That Pay You Soon (But You Must Act Quickly)

3 Absurdly Cheap Dividend Stocks to Buy With $1,000 in July

He Earned Six Figures Running Heavy Equipment. At 61, His Body Retired Before Social Security Would Let Him.

Single at 66 Means One Social Security Check and No Backup. These 4 ETFs Build the Second One

How a 59-Year-Old Built a $4,700 Monthly Paycheck Around SCHD, VICI, and ARCC

He Earned Six Figures Running Heavy Equipment. At 61, His Body Retired Before Social Security Would Let Him.

How a 59-Year-Old Built a $4,700 Monthly Paycheck Around SCHD, VICI, and ARCC

He Earned Six Figures Running Heavy Equipment. At 61, His Body Retired Before Social Security Would Let Him.

Single at 66 Means One Social Security Check and No Backup. These 4 ETFs Build the Second One

Pfizer : PFE

All Pfizer Articles

Verizon Was Booted From the Dow – 5 Dividend Giants Got the Same Treatment and Eventually Soared

2 Absurdly Cheap Healthcare Stocks to Buy Before July Ends

Boomers Swear by These High-Yield 5% and More Kings They Can Buy and Hold Forever

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King

Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?

This Healthcare Giant Still Checks Every Box for Long-Term Investors

Pfizer Vs. Amgen: Bet That Pfizer’s Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

McDonald’s or Pfizer: One Offers Real Growth, One Just Pays You to Wait

‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

3 High-Yield Dividends That Pay You Soon (But You Must Act Quickly)

3 Absurdly Cheap Dividend Stocks to Buy With $1,000 in July

He Earned Six Figures Running Heavy Equipment. At 61, His Body Retired Before Social Security Would Let Him.

Single at 66 Means One Social Security Check and No Backup. These 4 ETFs Build the Second One

How a 59-Year-Old Built a $4,700 Monthly Paycheck Around SCHD, VICI, and ARCC

Featured Reads

He Earned Six Figures Running Heavy Equipment. At 61, His Body Retired Before Social Security Would Let Him.

How a 59-Year-Old Built a $4,700 Monthly Paycheck Around SCHD, VICI, and ARCC